Skip to content

13F-HR/A filed by Casdin Capital, LLC

Casdin Capital, LLC filed this 13F-HR/A for the quarter ended 2019-09-30, filed 2019-11-12, with 33 holding rows worth $999,623,300.

Accession
0001534261-19-000012
Filed
2019-11-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, amendment of type new holdings, 33 entries on the cover page, a total value of $999,623,300 stated on the cover page (in dollars after the unit check, H1), rows summing to $999,623,300 with VALUE read as dollars, detected, 13F file number 028-17113. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPARK THERAPEUTICS INC84652J103COM863,300$90,585,824dollars, detected
INVITAE CORP46185L103COM3,838,388$73,965,736dollars, detected
SAGE THERAPEUTICS INC78667J108COM400,000$73,236,000dollars, detected
BLUEPRINT MEDICINES CORP09627Y109COM940,000$69,061,800dollars, detected
CODEXIS INC192005106COM5,073,780$67,853,011dollars, detected
MYOKARDIA INC62857M105COM1,115,000$64,429,900dollars, detected
BLUEBIRD BIO INC09609G100COM612,500$56,239,750dollars, detected
FATE THERAPEUTICS INC31189P102COM2,550,000$51,765,000dollars, detected
SAREPTA THERAPEUTICS INC803607100COM880,000$50,903,250dollars, detected
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock600,000$48,252,000dollars, detected
BIOLIFE SOLUTIONS INC COM NEW09062W204Stock2,428,571$40,374,993dollars, detected
DIANTHUS THERAPEUTICS INC COM55910K108Stock3,048,121$31,273,721dollars, detected
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK1,128,075$30,706,202dollars, detected
AGIOS PHARMACEUTICALS INC00847X104COM935,000$30,294,000dollars, detected
AUDENTES THERAPEUTICS INC.05070R104Common Stock860,000$24,157,400dollars, detected
ILLUMINA INC452327109COM60,000$22,089,000dollars, detected
GENMARK DIAGNOSTICS INC372309104COM3,365,000$21,838,850dollars, detected
GRITSTONE BIO INC39868T105COM1,770,000$19,717,800dollars, detected
SANGAMO THERAPEUTICS INC800677106COM1,455,000$16,478,100dollars, detected
GLOBAL BLOOD THERAPEUTICS USD37890U108COM300,000$15,780,000dollars, detected
TRANSPORTATION & LOGISTI438083107COM820,000$14,579,650dollars, detected
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock463,125$13,439,762dollars, detected
EDITAS MEDICINE INC28106W103COM415,000$11,875,200dollars, detected
ALECTOR INC014442107COMMON STOCK811,039$11,695,182dollars, detected
CONSTELLATION PHARMACEUTICALS INC.210373106Common Stock1,523,960$9,844,781dollars, detected
TWIST BIOSCIENCE CORP90184D100COM300,000$8,703,000dollars, detected
DENALI THERAPEUTICS INC COM24823R105Stock400,000$8,304,000dollars, detected
CAREDX INC14167L103COM1,000,000$7,198,000dollars, detected
FULCRUM THERAPEUTICS INC359616109COMMON STOCK844,285$5,266,938dollars, detected
DECIPHERA PHARMACEUTICALS IN24344T101COM100,000$3,394,000dollars, detected
STOKE THERAPEUTICS INC86150R107COM130,000$2,479,450dollars, detected
TURNING PT THERAPEUTICS90041T108COM75,000$2,442,000dollars, detected
ORCHARD THERAPEUTICS PLC68570P101ADR310,000$1,399,000dollars, detected

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001534261-19-000011 superseded2019-11-12acceptance time not in the bulk data set
13F-HR/A 0001534261-19-000012this filing2019-11-12acceptance time not in the bulk data set
13F-HR/A 0001534261-20-000001 base2020-01-03acceptance time not in the bulk data set